Sustained improvement with iloprost in a COPD patient with severe pulmonary hypertension

Chest

Volumn 135, Issue 2, 2009, Pages 536-537

  Hegewald, Matthew J ^a,b   Elliott, C Gregory ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

COPD; Iloprost; Pulmonary hypertension

Indexed keywords

ILOPROST;

AGED; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 60249096834     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1515     Document Type: Article

References (6)

1. Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy: importance of pulmonary artery pressure. Chest 1995; 107:1193-1198
2. Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127:1531-1536
3. Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:189-194
4. Saadjian AY, Philip-Joet FF, Vestri R, et al. Long-term treatment of chronic obstructive lung disease by nifedipine: an 18-month haemodynamic study. Eur Respir J 1988; 1:716-720
5. Dernaika TA, Beavin ML, Kinasewitz GT. Iloprost improves gas exchange in COPD patients with pulmonary arterial hypertension (PAH) [abstract]. Am J Respir Crit Care Med 2008; 177:A443
6. Marino WD, Granville P. The effect of iloprost inhalation on gas exchange in patients with COPD [abstract]. Chest 2006; 130:178S